The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ

被引:277
|
作者
Guillermet-Guibert, Julie [1 ]
Bjorklof, Katja [1 ]
Salpekar, Ashreena [1 ]
Gonella, Cristiano [1 ]
Ramadani, Faruk [2 ]
Bilancio, Antonio [1 ]
Meek, Stephen [3 ]
Smith, Andrew J. H. [3 ]
Okkenhaug, Klaus [2 ]
Vanhaesebroeck, Bart [1 ]
机构
[1] Queen Mary Univ London, Inst Canc, Ctr Cell Signaling, London EC1M 6BQ, England
[2] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 3AT, England
[3] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
gene targeting; signaling; tyrosine kinase; Akt; insulin;
D O I
10.1073/pnas.0707761105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p110 isoforms of phosphoinositide,3-kinase (PI3K) are acutely regulated by extracellular stimuli. The class IA PI3K catalytic sub-units (p110 alpha, p110 beta, and p110 delta) occur in complex with a Src homology 2 (SH2) domain-containing p85 regulatory subunit, which has been shown to link p110 alpha and p110 delta to Tyr kinase signaling pathways. The p84/p101 regulatory subunits of the p110 gamma class IB PI3K lack SH2 domains and instead couple p110 gamma to G protein-coupled receptors (GPCRs). Here, we show, using small-molecule inhibitors with selectivity for p110 beta and cells derived from a p110 beta-deficient mouse line, that p110 beta is not a major effector of Tyr kinase signaling but couples to GPCRs. In macrophages, both p110 beta and p110 gamma contributed to Akt activation induced by the GPCR agonist complement 5a, but not by the Tyr kinase ligand colony-stimulating factor-1. In fibroblasts, which express p110 beta but not p110 gamma, p110 beta mediated Akt activation by the GPCR ligands stromal cell-derived factor, sphingosine-1-phosphate, and lysophosphatidic acid but not by the Tyr kinase ligands PDGF, insulin, and insulin-like growth factor 1. Introduction of p110 gamma in these cells reduced the contribution of p110 beta to GPCR signaling. Taken together, these data show that p110 beta and p110 gamma can couple redundantly to the same GPCR agonists. p110 beta, which shows a much broader tissue distribution than the leukocyterestricted p110 gamma, could thus provide a conduit for GPCR-linked PI3K signaling in the many cell types where p110 gamma expression is low or absent.
引用
收藏
页码:8292 / 8297
页数:6
相关论文
共 50 条
  • [1] The p110α isoform of phosphoinositide 3-kinase is essential for cone photoreceptor survival
    Rajala, Raju V. S.
    Ranjo-Bishop, Michelle
    Wang, Yuhong
    Rajala, Ammaji
    Anderson, Robert E.
    [J]. BIOCHIMIE, 2015, 112 : 35 - 40
  • [2] p110 delta, a novel phosphoinositide 3-kinase in leukocytes
    Vanhaesebroeck, B
    Welham, MJ
    Kotani, K
    Stein, R
    Warne, PH
    Zvelebil, MJ
    Higashi, K
    Volinia, S
    Downward, J
    Waterfield, MD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4330 - 4335
  • [3] Human platelets contain p110δ phosphoinositide 3-kinase
    Zhang, J
    Vanhaesebroeck, B
    Rittenhouse, SE
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) : 178 - 181
  • [4] P110 delta, a novel human phosphoinositide 3-kinase
    Vanhaesebroeck, B
    Kotani, K
    Stein, RC
    Volinia, S
    Downward, J
    Waterfield, MD
    [J]. FASEB JOURNAL, 1996, 10 (06): : 2280 - 2280
  • [5] Eosinophilic esophagitis in patients with Phosphoinositide 3-Kinase p110δ
    Lawson, Jamie
    Uzel, Gulbu
    Webster, Sharon
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S154 - S154
  • [6] p110γ and p110δ isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease
    Saudemont, Aurore
    Garcon, Fabien
    Yadi, Hakim
    Roche-Molina, Marta
    Kim, Nayoung
    Segonds-Pichon, Anne
    Martin-Fontecha, Alfonso
    Okkenhaug, Klaus
    Colucci, Francesco
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) : 5795 - 5800
  • [7] Expression of the phosphoinositide 3-kinase p110δ isoform and its clinicopathological significance in gastric cancer
    Ji, Byounghoon
    Lee, Hyoun Wook
    Lee, Eun Hee
    Park, Moon-Il
    Kim, Mee-Seon
    Kim, Kyungeun
    Roh, Mee Sook
    Kim, Seok-Hyun
    Ji, Jun Ho
    Kim, Kwang Min
    Oh, Jieun
    Kim, Yong Seok
    Choi, Seong Hee
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9415 - 9421
  • [8] Targeting the phosphoinositide 3-kinase isoform p110δ impairs growth and survival in neuroblastoma cells
    Boller, Danielle
    Schramm, Alexander
    Doepfner, Kathrin T.
    Shalaby, Tarek
    von Bueren, Andre O.
    Eggert, Angelika
    Grotzer, Michael A.
    Arcaro, Alexandre
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1172 - 1181
  • [9] Novel approaches to inhibitor design for the p110β phosphoinositide 3-kinase
    Dbouk, Hashem A.
    Backer, Jonathan M.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (03) : 149 - 153
  • [10] The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells
    Okkenhaug, Klaus
    Patton, Daniel T.
    Bilancio, Antonio
    Garcon, Fabien
    Rowan, Wendy C.
    Vanhaesebroeck, Bart
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (08): : 5122 - 5128